Inozyme Pharma, Inc. (INZY)
NASDAQ: INZY · Real-Time Price · USD
1.005
+0.005 (0.53%)
Mar 14, 2025, 11:29 AM EDT - Market open
Inozyme Pharma Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Mar '25 Mar 14, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 65 | 178 | 263 | 42 | 161 | 482 | |
| Market Cap Growth | -32.37% | -32.37% | 520.31% | -73.72% | -66.54% | - | |
| Enterprise Value | -2 | 93 | 105 | -92 | 40 | 323 | |
| Last Close Price | 1.00 | 2.77 | 4.26 | 1.05 | 6.82 | 20.64 | |
| PB Ratio | 1.11 | 3.08 | 1.87 | 0.36 | 1.48 | 3.05 | |
| P/TBV Ratio | 3.08 | 3.08 | 1.87 | 0.36 | 1.48 | 3.05 | |
| Debt / Equity Ratio | 0.81 | 0.81 | 0.33 | 0.06 | 0.03 | - | |
| Quick Ratio | 3.35 | 3.35 | 12.87 | 8.70 | 9.62 | 14.83 | |
| Current Ratio | 3.56 | 3.56 | 13.36 | 8.93 | 9.92 | 15.14 | |
| Return on Equity (ROE) | -102.90% | -102.90% | -54.98% | -58.91% | -42.36% | -55.64% | |
| Return on Assets (ROA) | -40.13% | -40.13% | -27.81% | -32.67% | -24.17% | -32.81% | |
| Return on Capital (ROIC) | -44.57% | -44.57% | -30.28% | -36.10% | -26.15% | -35.16% | |
| Earnings Yield | -158.86% | -57.33% | -27.05% | -158.11% | -35.08% | -11.70% | |
| FCF Yield | -143.21% | -51.68% | -26.98% | -137.15% | -30.08% | -7.57% | |
| Buyback Yield / Dilution | -21.17% | -21.17% | -37.27% | -60.30% | -113.46% | -832.81% | |
| Total Shareholder Return | -21.17% | -21.17% | -37.27% | -60.30% | -113.46% | -832.81% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.